Article Versions Notes

Akioka T, Kimura S, Katayama Y, Fujii M, Kiwaki T, Kawaguchi M, Fukushima T, Sato Y, Mukai S, Kamoto T, et al. Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy. Biomedicines. 2025; 13(4):811. https://doi.org/10.3390/biomedicines13040811

Akioka, Takahiro, Shoichi Kimura, Yuichi Katayama, Masato Fujii, Takumi Kiwaki, Makiko Kawaguchi, Tsuyoshi Fukushima, Yuichiro Sato, Shoichiro Mukai, Toshiyuki Kamoto, and et al. 2025. "Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy" Biomedicines 13, no. 4: 811. https://doi.org/10.3390/biomedicines13040811

Akioka, T., Kimura, S., Katayama, Y., Fujii, M., Kiwaki, T., Kawaguchi, M., Fukushima, T., Sato, Y., Mukai, S., Kamoto, T., & Sawada, A. (2025). Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy. Biomedicines, 13(4), 811. https://doi.org/10.3390/biomedicines13040811